Keynote Forum: Accelerating Global Innovation with China's Efficiency

Frontier technologies of new drugs in China

• Non‑clinical Assessment of Novel High‑Potential Drugs

• Nanobody Drug R&D Session

• CNS Novel Drug R&D Session

• ATMP & CGT Global Expansion Session

• Next-Generation AAV Innovation & Advancement Special Session

• Stem Cell and Regenerative Medicine New Technology Session

• Patient-Centric Stem Cell New Drug R&D Innovation Practice Session

• Advanced Stem Cell Culture Technology Session

• In-Vivo CAR-T and Cellular Therapy Session

• Global Session on Small Nucleic Acid Drug Innovation

• Global Innovation of Antibodies and ADCs session

• R&D Strategies for Developing Innovative Drug Molecules Session

• Innovative Small Molecule Chemical Drugs Session

• Peptide Drug R&D Frontier Session

• Breakthroughs in Next-Generation Innovative Therapies

• The Booming Radiopharmaceuticals Session

• Novel Anti-Tumor and Autoimmune Therapeutics Session

• Nanobody Drug R&D Session

AI driven health industry

• AI·Intelligent Transformation: From Data Foundation to Scenario Value

• AI-Driven Innovation Practices for Pharmaceutical Enterprises

• Panel Discussion: AI-Empowered Four-in-One Translation Platform

• Future-Driven Intelligent R&D–AI for Life Science and Drug Discovery

• AI for Science Reshaping Innovative Drug R&D Session

• Computing Power × Mental Power × R&D Power: New Paradigms of Innovative Drug R&D in the AI Era Session

• AI Reshaping the End-to-End Clinical R&D Session

• The Era of Superintelligent Agents for Chinese Innovative Drugs

Policy regulation and intellectual property compliance

• Decree No. 818 and a New Era for the Development of Biomedicine Industry session

• IIT Supervision Model and China’s Innovation Efficiency Session

Drug production and supply chain management

• Antibody and ADC Drug Intelligent Manufacturing Session

• Build Innovation & Collaborative Ecosystem for Biopharma Supply Chain

Medical engineering integration and innovative medical devices

• Brain-Computer Interface Session

• International Advanced Drug Delivery Systems / Drug-Device Combinations Session

• Roadshow session for biomanufacturing projects

Investment and financing, corporate listing, and mergers and acquisitions

• Industrial Securities Session: Ushering in a New Era of Precision Oncology

• Soochow Pharma Special Session: Diversified Payment Models and Global Competitiveness of Innovative Drugs

• Cross-border Investment Session

• The Evolution and Beyond of NewCo Session

• China Healthcare M&A Session ——Convergence & Transformation: The Next Decade of China’s Healthcare M&A Market

• Embracing a New Era of Pharma BD

Cross border cooperation and the export of Chinese new drugs

• Legal Safeguard and Value Empowerment for Globalization of Chinese Pharma Enterprises

• China-Japan Cooperation Session: Leveraging Japan’s Market to Boost Overseas Expansion Strategies

• Capital Strategies and Hong Kong IPOs for Biopharmaceutical Enterprises

• China-Europe Healthcare Industry Session：Europe Meets China Speed

• Deepening the Footprint in Global Emerging Markets to Deliver Full-Chain Value of Chinese Innovative Drugs

• Global Development of Pharmaceutical Companies and Emerging Market Cooperation Session

• China–U.S. Collaboration Forum: Accelerating Global Drug Development Through Chinese Innovation

• Merits & Tree Law Offices Session:From IP to BD——China Innovative Drug Transaction Competency

• U.S. Biotech Tensions and the Future Road for Chinese Pharmaceutical Companies Going Global Session

• Clinical Development of Next-Generation Innovative Oncology Drugs

• Hong Kong Global Opportunities Session

• Vaccine Innovation and Global Expansion

• Protheragen Session: Global Biomedical Cross-Border Transactions

• Biosimilars Commercialization & Global Launch Session（China Focus）

• Collaboration Between North American and Chinese Innovative Drug Industries

• Global BD Cooperation Session for Innovative Drugs – Track 1, 2 & 3

• Workshop: The Key to Win Biotech Global BD Deals

China's Innovation Ecology and Innovation Model

• The Path to Innovation and Transformation for Traditional Pharmaceutical Companies

• Biopharmaceutical Industrial Park Development Session

• Clinical Innovation and Translation in China: Innovation Begins at the Bedside

• Ecosystem Transformation of Biomedical Innovation

• Bank Support for Innovative Drugs and Medical Devices Conference

• CPIC Roadshow Session

• Bio-Link Capital Roadshow Session

CPIC Suzhou Branch Venue

• Suzhou Industrial Park Satellite Session: Going Global & BD Transaction Dialogue